Literature DB >> 2933451

Modulation of suppressor T cell induction with gamma-interferon.

T Noma, M E Dorf.   

Abstract

The ability of antigen-coupled splenic adherent cells to induce suppressor T cells (Ts) is dependent on the presence of I-J determinants on antigen-presenting cells. After 4 days of in vitro culture, antigen-coupled adherent cells lose the capacity to induce Ts. Supernatants from Con A-stimulated lymphocyte cultures and purified interferon-gamma can sustain accessory function for the induction of Ts. Furthermore, after in vitro culture of splenic adherent cells, there is an apparent correlation between the loss of I-A determinants and the decrease in I-J-restricted Ts induction. Stimulation of Ia expression with interferon-gamma results in a simultaneous increase in the ability to induce Ts. Finally, elimination of I-A-bearing splenic adherent cells with antibody + C eliminates I-J-restricted Ts induction. The combined data imply a co-regulation of I-A and I-J on the antigen-presenting cells involved in the induction of both the Ts1 and Ts3 suppressor T cell subsets.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2933451

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  3 in total

1.  Suppression of experimental allergic encephalomyelitis by intraventricular administration of interferon-gamma in Lewis rats.

Authors:  J A Voorthuis; B M Uitdehaag; C J De Groot; P H Goede; P H van der Meide; C D Dijkstra
Journal:  Clin Exp Immunol       Date:  1990-08       Impact factor: 4.330

2.  Brucella abortus regulates bovine macrophage-T-cell interaction by major histocompatibility complex class II and interleukin-1 expression.

Authors:  G A Splitter; K M Everlith
Journal:  Infect Immun       Date:  1989-04       Impact factor: 3.441

3.  Enhancement of DTH reaction and inhibition of the expression of class II transplantation antigens by in vivo treatment with antibodies against gamma-interferon.

Authors:  C Skoglund; A Scheynius; R Holmdahl; P H Van der Meide
Journal:  Clin Exp Immunol       Date:  1988-03       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.